Suppr超能文献

欧盟传统草药药品指令(指令 2004/24/EC)会否对欧盟市场的中药不利?

Will the Europe Union's Traditional Herbal Medicinal Products Directive (Directive 2004/24/EC) be against traditional Chinese medicine in EU market?

机构信息

Shanghai Clinical Research Center, Shanghai, China.

出版信息

J Evid Based Med. 2013 May;6(2):104-8. doi: 10.1111/jebm.12036.

Abstract

As human civilization develops, biomedicine stays robust. Faced with the challenge of Europe Union's Traditional Herbal Medicinal Products Directive, if traditional Chinese medicine (TCM) wants to be still used as one kind of medicine to treat patients, China should be in line with scientific law, that is, each claim that TCM treats any disease or indication should be supported by the data of evidence-based randomized clinical trials. As a priority, there is an urgent need to conduct more scientific experiments and clinical trials to verify the concepts and mechanisms of TCM. Also, China is encouraged to get rid of non-scientific concepts and theories of TCM.

摘要

随着人类文明的发展,生物医药领域蓬勃发展。面对欧盟《传统植物药指令》的挑战,如果中药(TCM)仍希望作为一种药物来治疗患者,中国应该遵循科学规律,即 TCM 治疗任何疾病或适应症的每一个说法都应该得到基于证据的随机临床试验数据的支持。作为当务之急,迫切需要开展更多的科学实验和临床试验,以验证 TCM 的概念和机制。此外,中国应鼓励摆脱 TCM 的非科学概念和理论。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验